BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 320448)

  • 1. Combination of cyclophosphamide, vincristine, and prednisone, followed by maintenance chemotherapy, with and without radiotherapy, in the management of patients with non-Hodgkin's lymphomas.
    Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
    Med Pediatr Oncol; 1977; 3(1):41-51. PubMed ID: 320448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cyclophosphamide-vincristine-prednisone combination in the treatment of lympho- and reticulosarcomas in adults (60 cases)].
    Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
    Nouv Presse Med; 1976 Nov; 5(38):2525-30. PubMed ID: 790316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas a report of 131 cases.
    Parlier Y; Gorin NC; Najman A; Stachowiak J; Duhamel G
    Cancer; 1982 Aug; 50(3):401-9. PubMed ID: 7046899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
    Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
    Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata.
    Bonadonna G; De Lena M; Lattuada A; Milani F; Monfardini S; Beretta G
    Br J Cancer Suppl; 1975 Mar; 2():481-8. PubMed ID: 52367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide, vincristine, and prednisone (CVP) versus adriamycin, bleomycin, and prednisone (ABP) in stage IV non-Hodgkin's lymphomas.
    Monfardini S; Tancini G; DeLena M; Villa E; Valagussa P; Bonadonna G
    Med Pediatr Oncol; 1977; 3(1):67-74. PubMed ID: 65728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
    Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
    Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.
    Bonadonna G; Monfardini S; Villa E
    Cancer Treat Rep; 1977 Sep; 61(6):1117-23. PubMed ID: 71209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
    Durant JR; Loeb V; Dorfman R; Chan YK
    Cancer; 1975 Dec; 36(6):1936-44. PubMed ID: 1106833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Durant JR; Gams RA; Bartolucci AA; Dorfman RF
    Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in advanced non-Hodgkin's lymphomas.
    Portlock CS; Rosenberg SA
    Cancer; 1976 Mar; 37(3):1275-82. PubMed ID: 1260652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen.
    Klasa RJ; Meyer RM; Shustik C; Sawka CA; Smith A; Guévin R; Maksymiuk A; Rubinger M; Samosh M; Laplante S; Grenier JF
    J Clin Oncol; 2002 Dec; 20(24):4649-54. PubMed ID: 12488409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy of lymphomas other than Hodgkin's disease.
    Stein RS; Moran EM; Desser RK; Miller JB; Golomb HM; Ultmann JE
    Ann Intern Med; 1974 Nov; 81(5):601-8. PubMed ID: 4608355
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
    Schein PS; Chabner BA; Canellos GP; Young RC; DeVita VT
    Cancer; 1975 Feb; 35(2):354-7. PubMed ID: 1089470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
    Bennett JM; Lenhard RE; Ezdinli E; Johnson GJ; Carbone PP; Pocock SJ
    Cancer Treat Rep; 1977 Sep; 61(6):1079-83. PubMed ID: 71207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas.
    Pan D; Qin J; Farber C; O'Brien J; Filippa D; Portlock CS
    Leuk Lymphoma; 2003 Jun; 44(6):967-71. PubMed ID: 12854895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of diffuse histiocytic and diffuse mixed non-Hodgkin lymphomas with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP).
    Cohen Y; Epelbaum R; Ben-Shahar M; Ron Y; Haim N
    Acta Oncol; 1988; 27(5):531-5. PubMed ID: 3203011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
    Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study.
    Laver JH; Mahmoud H; Pick TE; Hutchison RE; Weinstein HJ; Schwenn M; Weitzman S; Murphy SB; Ochoa S; Shuster JJ
    Leuk Lymphoma; 2002 Jan; 43(1):105-9. PubMed ID: 11908712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.
    Luce JK; Gamble JF; Wilson HE; Monto RW; Isaacs BL; Palmer RL; Coltman CA; Hewlett JS; Gehan EA; Frei E
    Cancer; 1971 Aug; 28(2):306-17. PubMed ID: 4935774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.